A detailed history of Clearstead Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 889 shares of PCVX stock, worth $93,842. This represents 0.0% of its overall portfolio holdings.

Number of Shares
889
Previous 775 14.71%
Holding current value
$93,842
Previous $52,000 28.85%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$60.06 - $78.77 $6,846 - $8,979
114 Added 14.71%
889 $67,000
Q1 2024

May 14, 2024

BUY
$59.79 - $81.05 $14,050 - $19,046
235 Added 43.52%
775 $52,000
Q4 2023

Feb 12, 2024

BUY
$45.35 - $63.41 $5,895 - $8,243
130 Added 31.71%
540 $33,000
Q3 2023

Nov 07, 2023

BUY
$46.0 - $53.1 $18,860 - $21,771
410 New
410 $20,000

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $6.26B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.